United Capital Financial Advisors’s First Trust Health Care AlphaDEX Fund FXH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-3,381
| Closed | -$328K | – | 1082 |
|
|
2023
Q3 | $328K | Sell |
3,381
-650
| -16% | -$67.4K | ﹤0.01% | 716 |
|
|
2023
Q2 | $437K | Buy |
4,031
+20
| +0.5% | +$2.14K | ﹤0.01% | 699 |
|
|
2023
Q1 | $431K | Sell |
4,011
-2,422
| -38% | -$264K | ﹤0.01% | 751 |
|
|
2022
Q4 | $699K | Sell |
6,433
-200
| -3% | -$21K | ﹤0.01% | 695 |
|
|
2022
Q3 | $645K | Sell |
6,633
-301
| -4% | -$31.7K | ﹤0.01% | 705 |
|
|
2022
Q2 | $715K | Sell |
6,934
-562
| -7% | -$60.5K | ﹤0.01% | 706 |
|
|
2022
Q1 | $859K | Sell |
7,496
-4,357
| -37% | -$488K | ﹤0.01% | 700 |
|
|
2021
Q4 | $1.47M | Sell |
11,853
-370
| -3% | -$44.3K | 0.01% | 601 |
|
|
2021
Q3 | $1.46M | Buy |
12,223
+792
| +7% | +$96.9K | 0.01% | 588 |
|
|
2021
Q2 | $1.34M | Buy |
11,431
+123
| +1% | +$14K | 0.01% | 624 |
|
|
2021
Q1 | $1.23M | Sell |
11,308
-320
| -3% | -$35K | 0.01% | 613 |
|
|
2020
Q4 | $1.25M | Sell |
11,628
-750
| -6% | -$76.3K | 0.01% | 618 |
|
|
2020
Q3 | $1.17M | Sell |
12,378
-83
| -0.7% | -$7.78K | 0.01% | 614 |
|
|
2020
Q2 | $1.12M | Sell |
12,461
-477
| -4% | -$40.9K | 0.01% | 631 |
|
|
2020
Q1 | $957K | Sell |
12,938
-12,130
| -48% | -$985K | 0.01% | 644 |
|
|
2019
Q4 | $2.11M | Sell |
25,068
-1,096
| -4% | -$86.8K | 0.01% | 596 |
|
|
2019
Q3 | $1.94M | Hold |
26,164
| – | – | 0.01% | 592 |
|
|
2019
Q2 | $2.03M | Sell |
26,164
-9,583
| -27% | -$712K | 0.01% | 623 |
|
|
2019
Q1 | $2.73M | Sell |
35,747
-150
| -0.4% | -$11.2K | 0.02% | 525 |
|
|
2018
Q4 | $2.47M | Buy |
35,897
+4,905
| +16% | +$372K | 0.02% | 512 |
|
|
2018
Q3 | $2.63M | Buy |
30,992
+652
| +2% | +$52.1K | 0.02% | 547 |
|
|
2018
Q2 | $2.25M | Sell |
30,340
-2,595
| -8% | -$188K | 0.02% | 570 |
|
|
2018
Q1 | $2.29M | Sell |
32,935
-2,836
| -8% | -$205K | 0.02% | 554 |
|
|
2017
Q4 | $2.5M | Sell |
35,771
-3,512
| -9% | -$240K | 0.02% | 541 |
|
|
2017
Q3 | $2.65M | Sell |
39,283
-4,931
| -11% | -$329K | 0.02% | 512 |
|
|
2017
Q2 | $2.96M | Sell |
44,214
-229,192
| -84% | -$14.7M | 0.03% | 484 |
|
|
2017
Q1 | $17.1M | Sell |
273,406
-93,079
| -25% | -$5.68M | 0.16% | 148 |
|
|
2016
Q4 | $21M | Sell |
366,485
-27,502
| -7% | -$1.59M | 0.2% | 105 |
|
|
2016
Q3 | $24M | Sell |
393,987
-13,549
| -3% | -$824K | 0.23% | 96 |
|
|
2016
Q2 | $24M | Buy |
407,536
+173,175
| +74% | +$10M | 0.24% | 83 |
|
|
2016
Q1 | $13.1M | Sell |
234,361
-68,769
| -23% | -$3.72M | 0.14% | 151 |
|
|
2015
Q4 | $18.3M | Sell |
303,130
-175,582
| -37% | -$10.5M | 0.21% | 96 |
|
|
2015
Q3 | $27.9M | Buy |
478,712
+88,332
| +23% | +$5.86M | 0.33% | 52 |
|
|
2015
Q2 | $26.9M | Sell |
390,380
-16,208
| -4% | -$1.1M | 0.31% | 74 |
|
|
2015
Q1 | $26.3M | Buy |
+406,588
| New | +$25.9M | 0.32% | 80 |
|
Other funds holding FXH
RJFSA
RJA
United Capital Financial Advisors's FXH Position: Q4 2023 in Review
United Capital Financial Advisors sold out of First Trust Health Care AlphaDEX Fund (FXH) in Q4 2023, closing a stake of 3,381 shares — an estimated $328K sold.
United Capital Financial Advisors first reported a position in FXH in Q1 2015 and held it in 35 quarters. The position peaked at $27.9M in Q3 2015. 262 funds tracked by Wall St. Rank hold FXH as of Q4 2023.
- United Capital Financial Advisors reported no remaining First Trust Health Care AlphaDEX Fund position as of Q4 2023 after selling out during the quarter.
- United Capital Financial Advisors sold 3,381 First Trust Health Care AlphaDEX Fund shares in Q4 2023, an estimated $328K.
- United Capital Financial Advisors first reported a position in First Trust Health Care AlphaDEX Fund in Q1 2015 and held it in 35 quarters.
- United Capital Financial Advisors's First Trust Health Care AlphaDEX Fund position peaked at $27.9M in Q3 2015.
- 262 funds tracked by Wall St. Rank held First Trust Health Care AlphaDEX Fund as of Q4 2023.
Based on United Capital Financial Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.